CBRN Defense · Public Health & Prevention
Emergent BioSolutions revenue, results and funding
Emergent BioSolutions filed revenue of $742.9M for 2025.
Data updated Nov 17, 2026 · Back to the company report
$742.9MRevenue, 2025
$52.6MNet income, 2025
$47.9MTotal raised
Results by year
| Year | Revenue | Net income | Total assets |
|---|---|---|---|
| 2025 | $742.9M | $52.6M | $1.3B |
| 2024 | $1B | −$190.6M | $1.4B |
| 2023 | $1B | −$760.5M | $1.8B |
| 2022 | $1.1B | −$211.6M | $3.2B |
| 2021 | $1.8B | $219.5M | $3B |
| 2020 | $1.6B | $305.8M | $2.9B |
| 2019 | $1.1B | $54.5M | $2.3B |
| 2018 | $782.4M | $62.7M | $2.2B |
| 2017 | $560.9M | $82.6M | $1.1B |
| 2016 | $488.8M | $51.8M | $970.1M |
| 2015 | $522.8M | $62.9M | $1B |
| 2014 | $450.1M | $36.7M | $938.7M |
| 2013 | $312.7M | $31.1M | $626.6M |
| 2012 | $281.9M | $23.5M | $564.2M |
| 2011 | $273.4M | $23M | $546.9M |
Sources: SEC
Rounds and grants
| Year | Round | Amount |
|---|---|---|
| 2018 | Venture | $47.9M |
Sources: funding announcements, SEC filings, grant registers
How to cite
Emergent BioSolutions, Financials. Alion, Nov 17, 2026. https://alion.io/company/emergentbiosolutions/financials
